Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention

References

• CDC. Unexplained Immunodeficiency and Opportunistic Infections in Infants – New York, New Jersey, California. 1982. [cited 2020 Jan 21]. https://www.cdc.gov/mmwr/preview/mmwrhtml/00001208.htm
   Google Scholar
• Nesheim SR, Wiener J, Fitz Harris LF, et al. Estimated incidence of perinatally acquired hiv infection in the United States, 1978–2013. J Acquir Immune Defic Syndr. 2017;76(5):461–464.
   PubMed Web of Science ®Google Scholar
• CDC. HIV and African Americans/Race/Ethnicity/HIV by Group/HIV/AIDS/CDC. Published April 6, 2020. [cited 2020 May 15]. https://www.cdc.gov/hiv/group/racialethnic/africanamericans/index.html
   Google Scholar
• CDC. Achievements in Public Health: reduction in Perinatal Transmission of HIV Infection — united States, 1985–2005. 2006. [cited 2020 Jan 22]. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5521a3.htm
   Google Scholar
• CDC. Statistics Overview/HIV/AIDS/CDC. Published November 21, 2019. [cited 2020 Jan 22]. https://www.cdc.gov/hiv/statistics/overview/index.html
   Google Scholar
• CDC. Pregnant Women, Infants, and Children/Gender/HIV by Group/HIV/AIDS/CDC. Published November 12, 2019. [cited 2020 Jan 22]. https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html
   Google Scholar
• CDC. Pediatric HIV Surveillance 2018. [cited 2020 May 26]. https://www.cdc.gov/hiv/pdf/library/slidesets/cdc-hiv-surveillance-pediatric-2018.pdf
   Google Scholar
• US DHHS. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. [cited 2020 Mar 17]. https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/9/treatment-goals
   Google Scholar
• Neilan AM, Karalius B, Patel K, et al. Association of risk of viremia, immunosuppression, serious clinical events, and mortality with increasing age in perinatally human immunodeficiency virus–infected youth. JAMA Pediatr. 2017;171(5):450–460.
   PubMed Web of Science ®Google Scholar
• CDC. Understanding the HIV care continuum. Published April 2019. [cited 2020 Feb 10]. https://www.cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf
   Google Scholar
• Xia Q, Shah D, Gill B, et al. Continuum of Care Among People Living with Perinatally Acquired HIV Infection in New York City, 2014. 433021. 2016;131(4):566–573.
   Google Scholar
• Judd A, Le Prevost M, Melvin D, et al. Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: role of Non-HIV-Related Factors. Clin Infect Dis. 2016;63(10):1380–1387.
   PubMed Web of Science ®Google Scholar
• Madiba S, Josiah U. Perceived stigma and fear of unintended disclosure are barriers in medication adherence in adolescents with perinatal HIV in Botswana: a qualitative study. Biomed Res Int. 2019;2019:9623159. DOI:10.1155/2019/9623159.
   Web of Science ®Google Scholar
• Wiener LS, Battles HB, Wood LV. A longitudinal study of adolescents with perinatally or transfusion acquired HIV infection: sexual knowledge, risk reduction self-efficacy and sexual behavior. AIDS Behav. 2007;11(3):471–478.
   PubMed Web of Science ®Google Scholar
• Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, et al. Youth at risk of HIV: the overlooked US HIV prevention crisis. Lancet HIV. 2019;6(5):e275–e8.
   PubMed Web of Science ®Google Scholar
• CDC. HIV surveillance - adolescents and young adults. 2018; [cited 2020 May 26]. https://www.hiv.uw.edu/pdf/key-populations/pediatric-adolescents-young-adults-hiv/core-concept/all
   Google Scholar
• CDC. Epidemiology of HIV Infection. 2018. [cited 2020 May 26]. https://www.cdc.gov/hiv/pdf/library/slidesets/cdc-hiv-surveillance-epidemiology-2018.pdf
   Google Scholar
• UNAIDS. Global HIV Statistics. 2019. [cited 2020 Apr 29]. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
   Google Scholar
• Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res. 2010;85(1):1.
   PubMed Web of Science ®Google Scholar
• U.S DHHS. FDA-Approved HIV Medicines: understanding HIV/AIDS. [cited 2020 Feb 17]. https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/58/fda-approved-hiv-medicines
   Google Scholar
• US. DHHS. What’s New in the Guidelines: Pediatric ARV. [cited 2020 Jan 30]. https://aidsinfo.nih.gov/guidelines/html/2/pediatric-arv/45/whats-new-in-the-guidelines
   Google Scholar
• IMPAACT. Ongoing Studies. cited 2020 Feb 18. https://www.impaactnetwork.org/studies/
   Google Scholar
• Altice F, Evuarherhe O, Shina S, et al. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence. 2019;13:475–490.
   PubMed Web of Science ®Google Scholar
• Reisner SL, Mimiaga MJ, Skeer M, et al. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14–25.
   PubMedGoogle Scholar
• Gare J, Ryan CE, David M, et al. Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea. J Antimicrob Chemother. 2014;69(8):2183–2186.
   PubMed Web of Science ®Google Scholar
• Memarnejadian A, Nikpoor AR, Davoodian N, et al. HIV-1 drug resistance mutations among antiretroviral drug-experienced patients in the South of Iran. Intervirology. 2019;62(2):72–79.
   PubMed Web of Science ®Google Scholar
• Dollfus C, Le Chenadec J, Faye A, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010;51(2):214–224.
   PubMed Web of Science ®Google Scholar
• Nichols SL, Montepiedra G, Farley JJ, et al. Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection. J Dev Behav Pediatr. 2012;33(4):298–308.
   PubMed Web of Science ®Google Scholar
• Saitoh A, Foca M, Viani RM, et al. Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection. Pediatrics. 2008;121(3):e513–21.
   PubMed Web of Science ®Google Scholar
• Maslowsky J, Owotomo O, Huntley ED, et al. Adolescent risk behavior: differentiating reasoned and reactive risk-taking. J Youth Adolesc. 2019;48(2):243–255.
   PubMed Web of Science ®Google Scholar
• Estripeaut D, Luciani K, García R, et al. Analysis of the social and psychosocial factors associated with adherence to antiretroviral therapy in adolescents with perinatal HIV-1 infection in Panama from a gender perspective. AIDS Care. 2016;28(Suppl 2):66–72.
   PubMedGoogle Scholar
• Xu L, Munir K, Kanabkaew C, et al. Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand. PLoS ONE. 2017;12(2):e0172392.
   PubMed Web of Science ®Google Scholar
• Earnshaw VA, Kidman RC, Violari A. Stigma, Depression, and Substance Use Problems among Perinatally HIV-Infected Youth in South Africa. AIDS Behav. 2018;22(12):3892–3896.
   PubMed Web of Science ®Google Scholar
• Hawkins A, Evangeli M, Sturgeon K, et al., AALPHI Steering Committee. Episodic medication adherence in adolescents and young adults with perinatally acquired HIV: a within-participants approach. AIDS Care. 2016;28(Suppl 1):68–75.
   PubMedGoogle Scholar
• Raymond JF, Bucek A, Dolezal C, et al. Use of Unannounced Telephone Pill Counts to Measure Medication Adherence Among Adolescents and Young Adults Living With Perinatal HIV Infection. J Pediatr Psychol. 2017;42(9):1006–1015.
   PubMed Web of Science ®Google Scholar
• MacDonell K, Naar-King S, Huszti H, et al. Barriers to Medication Adherence in Behaviorally and Perinatally Infected Youth Living with HIV. AIDS Behav. 2013;17(1):86–93.
   PubMed Web of Science ®Google Scholar
• Agwu AL, Fairlie L. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc. 2013;16:18579.
   PubMed Web of Science ®Google Scholar
• Bucek A, Leu C-S, Benson S, et al. Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults. Pediatr Infect Dis J. 2018;37:673–677.
   PubMed Web of Science ®Google Scholar
• Van Dyke RB, Patel K, Kagan RM, et al. Antiretroviral Drug Resistance among Children and Youth in the United States with Perinatal HIV. Clin Infect Dis. 2016;63(1):133–137.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The Discovery and Development of Antiretroviral Agents. [cited 2020 Mar 16]. https://apps.who.int/medicinedocs/en/m/abstract/Js21619en/
   Google Scholar
• Tarantino N, Brown LK, Whiteley L, et al. Correlates of missed clinic visits among youth living with HIV. AIDS Care. 2018;30(8):982–989.
   PubMed Web of Science ®Google Scholar
• Collins IJ, Foster C, Tostevin A, et al. Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland. Clin Infect Dis. 2017;64(8):1105–1112.
   PubMed Web of Science ®Google Scholar
• Judd A, Lodwick R, Noguera-Julian A, et al. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med. 2017;18(3):171–180.
   PubMed Web of Science ®Google Scholar
• Contreras GA, Bell CS, Del Bianco G, et al. Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents. J Infect. 2016;72(3):353–361.
   PubMed Web of Science ®Google Scholar
• U.S DHHS. Virologic Failure: management of the Treatment-Experienced Patient Adult and Adolescent ARV. [cited 2020 May 16. https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/15/virologic-failure
   Google Scholar
• Griffith D, Farmer C, Gebo K, et al. Uptake and virologic outcomes of single versus multi-tablet antiretroviral regimen among treatment naïve youth in the HIV Research Network. HIV Med. 2019;20(2):169–174.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Clinical Guidelines: antiretroviral Therapy. [cited 2020 Jan 22]. https://www.who.int/hiv/pub/arv/chapter4.pdf
   Google Scholar
• Wiener L, Mellins CA, Marhefka S, et al. Disclosure of an HIV diagnosis to Children: history, Current Research, and Future Directions. J Dev Behav Pediatr. 2007;28(2):155–166.
   PubMed Web of Science ®Google Scholar
• Sahay S. Coming of age with HIV: a need for disclosure of HIV diagnosis among children/adolescents. J HIV/AIDS Infect Dis. 2013;1(1):1.
   Google Scholar
• Sabharwal S, Mitchell JW, Fan VY. Should there be a disclosure mandate for physicians caring for perinatally infected adolescents who don’t know their HIV serostatus? AMA J Ethics. 2018;20(8):743–749.
   Google Scholar
• CDC. HIV among Youth/Age/HIV by Group/Published December 2, 2019. [cited 2020 Mar 9]. https://www.cdc.gov/hiv/group/age/youth/index.html
   Google Scholar
• Ahmed SP, Bittencourt-Hewitt A, Sebastian CL. Neurocognitive bases of emotion regulation development in adolescence. Dev Cogn Neurosci. 2015;15:11–25.
   PubMed Web of Science ®Google Scholar
• Telzer EH, van Hoorn J, Rogers CR, et al. Social influence on positive youth development: a developmental neuroscience perspective. Adv Child Dev Behav. 2018;54:215–258.
   PubMed Web of Science ®Google Scholar
• Gray KM, Wang X, Li J, et al. Characteristics and Care Outcomes Among Persons Living With Perinatally Acquired HIV Infection in the United States, 2015. J Acquir Immune Defic Syndr. 2019;82(1):17–23.
   PubMed Web of Science ®Google Scholar
• Agwu AL, Lee L, Fleishman JA, et al. Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network. J Adolesc Health. 2015;56(3):345–351.
   PubMed Web of Science ®Google Scholar
• Society for Adolescent Health. Transition to Adult Health Services for Adolescents with chronic Conditions. cited 2020 Feb 21. https://www.racp.edu.au/docs/default-source/advocacy-library/transition-to-adult-health-services-for-adolescents-with-chronic-conditions.pdf
   Google Scholar
• Judd A, Davies M-A. Adolescent transition among young people with perinatal HIV in high-income and low-income settings. Curr Opin HIV AIDS. 2018;13(3):236–248.
   PubMed Web of Science ®Google Scholar
• Griffith DC, Agwu AL. Caring for youth living with HIV across the continuum: turning gaps into opportunities. AIDS Care. 2017;29(10):1205–1211.
   PubMed Web of Science ®Google Scholar
• Dahourou DL, Gautier-Lafaye C, Teasdale CA, et al. Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes. J Int AIDS Soc. 2017;20(Suppl3):21528.
   PubMedGoogle Scholar
• Kung TH, Wallace ML, Snyder KL, et al. South African healthcare provider perspectives on transitioning adolescents into adult HIV care. S Afr Med J. 2016;106(8):804–808.
   PubMedGoogle Scholar
• Xia Q, Abraham B, Shah D, et al. Transition from paediatric to adult care among persons with perinatal HIV infection in New York City, 2006-2015. AIDS. 2018;32(13):1821–1828.
   PubMed Web of Science ®Google Scholar
• Lee L, Yehia BR, Gaur AH, et al. The Impact of Youth-Friendly Structures of Care on Retention among HIV-Infected Youth. AIDS Patient Care STDS. 2016;30(4):170–177.
   PubMed Web of Science ®Google Scholar
• National Research Council and Institute of Medicine. Adolescent Health Services: missing Opportunities. National Academies Press; 2009. [cited 2020 Apr 29]. https://www.nap.edu/catalog/12063/adolescent-health-services-missing-opportunities
   Google Scholar
• Fisher JD, Smith L. Secondary prevention of HIV infection: the current state of prevention for positives. Curr Opin HIV AIDS. 2009;4(4):279–287.
   PubMed Web of Science ®Google Scholar
• Kann L, McManus T, Harris WA, et al. Youth Risk Behavior Surveillance —United States, 2017. MMWR Surveill Summ. 2018;67(8):479.
   Google Scholar
• Salih NA, Metaferia H, Reda AA, et al. Premarital sexual activity among unmarried adolescents in northern Ethiopia: a cross-sectional study. Sex Reprod Healthcare. 2015;6(1):9–13.
   PubMed Web of Science ®Google Scholar
• Mellins C, Tassiopoulos K, Malee K, et al. Behavioral health in perinatally HIV exposed youth: co-occurennce of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS. 2011;25:413–422.
   PubMed Web of Science ®Google Scholar
• Fortenberry JD. Puberty and adolescent sexuality. Horm Behav. 2013;64(2):280–287.
   PubMed Web of Science ®Google Scholar
• Judd A, Foster C, Thompson LC, et al. Sexual health of young people with perinatal HIV and HIV negative young people in England. PLoS ONE. 2018;13(10):e0205597.
   PubMed Web of Science ®Google Scholar
• Negriff S, Schneiderman JU, Trickett PK. Child maltreatment and sexual risk behavior: maltreatment types and gender differences. J Dev Behav Pediatr. 2015;36(9):708–716.
   PubMed Web of Science ®Google Scholar
• Ankunda R, Atuyambe LM, Kiwanuka N. Sexual risk related behaviour among youth living with HIV in central Uganda: implications for HIV prevention. Pan Afr Med J. 2016;24:49.
   Google Scholar
• Medin G, García-Navarro C, Navarro Gomez M, et al. Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study. AIDS Care. 2016;28(1):124–130.
   PubMed Web of Science ®Google Scholar
• CDC. STDs in Adolescents and Young Adults - 2018 Sexually Transmitted Diseases Surveillance. Published October 8, 2019. [cited 2020 Mar 4]. https://www.cdc.gov/std/stats18/adolescents.htm
   Google Scholar
• Kidman R, Nachman S, Dietrich J, et al. Childhood adversity increases the risk of onward transmission from perinatal HIV-infected adolescents and youth in South Africa. Child Abuse Negl. 2018;79:98–106.
   PubMed Web of Science ®Google Scholar
• Guttmacher Institute.Sex and HIV Education. Published March 14, 2016. [cited 2020 May 26. https://www.guttmacher.org/state-policy/explore/sex-and-hiv-education
   Google Scholar
• Brothers J, Hotton AL, Hosek SG, et al. Young Women Living with HIV: outcomes from a Targeted Secondary Prevention Empowerment Pilot Trial. AIDS Patient Care STDS. 2016;30(5):229–235.
   PubMed Web of Science ®Google Scholar
• Chandwani S, Abramowitz S, Koenig LJ, et al. A multimodal behavioral intervention to impact adherence and risk behavior among perinatally and behaviorally HIV-infected youth: description, delivery, and receptivity of adolescent impact. AIDS Educ Prev. 2011;23(3):222–235.
   PubMed Web of Science ®Google Scholar
• Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20(2):143–157.
   PubMed Web of Science ®Google Scholar
• LaGrange RD, Abramowitz S, Koenig LJ, et al. Participant satisfaction with group and individual components of Adolescent Impact: a secondary prevention intervention for HIV-positive youth. AIDS Care. 2012;24(1):119–128.
   PubMed Web of Science ®Google Scholar
• Moges NA, Bizuayehu HM. Sexual Behavior of Perinatally Infected Youth in Northwest Ethiopia: implication for HIV Prevention Strategy. AIDS Res Treat. 2018;2018:1573845.
   PubMed Web of Science ®Google Scholar
• Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR–03):1–137.
   PubMed Web of Science ®Google Scholar
• Kourtis AP, Mirza A. Committee on pediatric AIDS. Contraception for HIV-infected adolescents. Pediatrics. 2016;138(3):e20161892.
   PubMed Web of Science ®Google Scholar
• Brown JL, Haddad LB, Gause NK, et al. Examining the contraceptive decisions of young, HIV-infected women: a qualitative study. Women Health. 2019;59(3):305–317.
   PubMed Web of Science ®Google Scholar
• Copen CE. Condom use during sexual intercourse among women and men aged 15-44 in the United States: 2011-2015 national survey of family growth. Europe PMC. 2017;(105):1–18. [[cited 2020 May 26]]. https://europepmc.org/article/med/29155683
   Google Scholar
• Gursahaney PR, Cordes S, Ofotokun I, et al. Factors associated with condom use among HIV-positive women living in Atlanta, Georgia. PLoS One. 2019;14(12):e0225406.
   PubMed Web of Science ®Google Scholar
• Haddad LB, Brown JL, King C, et al. Contraceptive, condom and dual method use at last coitus among perinatally and horizontally HIV-infected young women in Atlanta, Georgia. PLoS One. 2018;13(9):e0202946.
   Web of Science ®Google Scholar
• Scarsi KK, Darin KM, Chappell CA, et al. Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV. Drug Saf. 2016;39(11):1053–1072.
   PubMed Web of Science ®Google Scholar
• Adler DH, Abar B, Bennie T, et al. Childbearing intentions among sexually active HIV-infected and HIV-uninfected female adolescents in South Africa. J AIDS HIV Res. 2017;9(7):159–163.
   PubMedGoogle Scholar
• Agwu AL, Jang SS, Korthuis PT, et al. Pregnancy Incidence and Outcomes Differ in Vertically and Behaviorally HIV-Infected Youth In a Multi-Site Clinical Cohort. JAMA. 2011;305(5):468–470.
   PubMed Web of Science ®Google Scholar
• Huang K-Y, Li Y-P, Shih -C-C, et al. Mother-to-child transmission of HIV: an 11-year experience in a single center and HIV prevention effectiveness in Taiwan. J Formosan Med Assoc. 2019;118(8):1211–1217.
   PubMed Web of Science ®Google Scholar
• Fatti G, Shaikh N, Eley B, et al. Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: a cohort study at public facilities in the Nelson Mandela Bay Metropolitan district, Eastern Cape, South Africa. S Afr Med J. 2014;104(12):874–880.
   PubMed Web of Science ®Google Scholar
• Prieto LM, Fernández McPhee C, Rojas P, et al. Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015. PLoS ONE. 2017;12(8):e0183558.
   PubMed Web of Science ®Google Scholar
• Badell ML, Kachikis A, Haddad LB, et al. Comparison of Pregnancies between Perinatally and Sexually HIV-Infected Women: an Observational Study at an Urban Hospital. Infect Dis Obstet Gynecol. 2013;2013:301763.
   PubMedGoogle Scholar
• Judd A, Chappell E, Turkova A, et al. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: a cohort study. PLoS Med. 2018;15(1):e1002491.
   PubMed Web of Science ®Google Scholar
• Wood S, Shah S, Steenhoff A, et al. The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. Aids. 2009;23(14):1859–1865.
   PubMed Web of Science ®Google Scholar
• Anglemyer A, Sturt A, Maldonado Y. The Effect of Combination Antiretroviral Therapy Use Among HIV Positive Children on the Hazard of AIDS Using Calendar Year as an Instrumental Variable. Curr HIV Res. 2018;16(2):151–157.
   PubMed Web of Science ®Google Scholar
• Teeraananchai S, Kerr SJ, Amin J, et al. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017;18(4):256–266.
   PubMed Web of Science ®Google Scholar
• Bhimma R, Purswani MU, Kala U. Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc. 2013;16:18596.
   PubMed Web of Science ®Google Scholar
• Jao J, Wyatt CM. Antiretroviral Medications: adverse Effects on the Kidney. ClinicalKey. 2010;17(1):72–82.
   Google Scholar
• Barlow-Mosha L, Eckard AR, McComsey GA, et al. Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc. 2013;16:18600.
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Warschburger P. Patterns of body image concerns in adolescence and early adulthood: a latent profile analysis. Eat Behav. 2018;29:28–34.
   PubMed Web of Science ®Google Scholar
• Jacobson DL, Patel K, Siberry GK, et al. Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study. Am J Clin Nutr. 2011;94(6):1485–1495. .
   PubMed Web of Science ®Google Scholar
• Norwood J, Turner M, Bofill C, et al. Brief Report. J Acquir Immune Defic Syndr. 2017;76(5):527–531. .
   PubMed Web of Science ®Google Scholar
• DiMeglio LA, Wang J, Siberry GK, et al. Bone mineral density in children and adolescents with perinatal HIV infection. AIDS. 2013;27(2):211–220.
   PubMed Web of Science ®Google Scholar
• Puthanakit T, Siberry GK. Bone health in children and adolescents with perinatal HIV infection. J Int AIDS Soc. 2013;16:18575.
   PubMed Web of Science ®Google Scholar
• Sudjaritruk T, Bunupuradah T, Aurpibul L, et al. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents. Antivir Ther (Lond). 2017;22(6):471–479.
   PubMed Web of Science ®Google Scholar
• Gafni RI, Hazra R, Reynolds JC, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics. 2006;118(3):e711–8.
   PubMed Web of Science ®Google Scholar
• Patel K, Wang J, Jacobson DL, et al. Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus. Circulation. 2014;129(11):1204–1212.
   PubMed Web of Science ®Google Scholar
• Githinji LN, Mahtab S, Zühlke L, et al. Cardiopulmonary dysfunction in perinatally HIV-infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort. J Int AIDS Soc. 2019;22(7):e25340.
   PubMed Web of Science ®Google Scholar
• Wilkinson JD, Williams PL, Yu W, et al. Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children. AIDS. 2018;32(10):1267–1277.
   PubMed Web of Science ®Google Scholar
• McCrary AW, Nyandiko W, Ellis AM, et al. Early cardiac dysfunction in children and young adults with perinatally acquired HIV. AIDS. 2019;34(4):539–548..
   Web of Science ®Google Scholar
• Malee KM, Tassiopoulos K, Huo Y, et al. Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care. 2011;23(12):1533–1544.
   PubMed Web of Science ®Google Scholar
• Kalungi A, Womersley JS, Kinyanda E, et al. Internalizing Mental Disorders and Accelerated Cellular Aging among Perinatally HIV-Infected Youth in Uganda. Front Genet. 2019;10:705.
   PubMed Web of Science ®Google Scholar
• Judd A, Sohn A, Collins I. Interventions to improve treatment, retention and survival outcomes for adolescents with perinatal HIV-1 transitioning to adult care: moving on up. Curr Opin HIV AIDS. 2016;11(5):477–486.
   PubMed Web of Science ®Google Scholar
• Kennard B, Brown L, Hawkins L, et al. Development and implementation of health and wellness CBT for individuals with depression and HIV. Cogn Behav Pract. 2014;21(2):237–246.
   PubMed Web of Science ®Google Scholar
• Vreeman RC, McCoy BM, Lee S. Mental health challenges among adolescents living with HIV. J Int AIDS Soc. 2017;20(3):21497.
   Google Scholar
• Kancheva Landolt N, Bunupuradah T, Achalapong J, et al. Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception. J Virus Erad. 2017;3(1):56–60.
   PubMedGoogle Scholar
• Innes S, Patel K. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS. 2018;13(3):187–195.
   PubMed Web of Science ®Google Scholar
• Ben-Avraham D. Epigenetics of aging. Adv Exp Med Biol. 2015;847:179–191.
   Google Scholar
• Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis. 2015;212(10):1563–1573.
   PubMed Web of Science ®Google Scholar
• Horvath S, Stein DJ, Phillips N, et al. Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents. AIDS. 2018;32(11):1465–1474.
   PubMed Web of Science ®Google Scholar
• HCF C, Soudeyns H, Thorne A, et al. Leukocyte telomere length in HIV-infected and HIV-exposed uninfected children: shorter telomeres with uncontrolled HIV viremia. PLoS ONE. 2012;7(7):e39266.
   PubMed Web of Science ®Google Scholar
• Izbudak I, Chalian M, Hutton N, et al. Perinatally HIV-Infected Youth Presenting with Acute Stroke: progression/Evolution of Ischemic Disease on Neuroimaging. J Neuroradiol. 2013;40(3):172–180.
   PubMed Web of Science ®Google Scholar
• Griffith DC, Aronis KN, Orozco AM, et al. Premature coronary artery disease and ST-elevation myocardial infarction in a 24-year-old man with perinatally acquired human immunodeficiency virus: a case report. Open Forum Infect Dis. 2017;4(1):1–4.
   PubMed Web of Science ®Google Scholar
• Bohlius J, Foster C, Naidu G, et al. Cancer in adolescents and young adults living with HIV. Curr Opin HIV AIDS. 2018;13(3):196–203.
   PubMed Web of Science ®Google Scholar
• Baecke C, Gyssens IC, Decoutere L, et al. Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study. Neth J Med. 2017;75(6):235–240.
   PubMed Web of Science ®Google Scholar
• Cordova E, Cecchini D, Rodriguez C. Potential drug-drug interactions in HIV-perinatally infected adolescents on antiretroviral therapy in Buenos Aires, Argentina. J Int AIDS Soc. 2014;17(4Suppl 3):19764.
   PubMedGoogle Scholar
• Hsu AJ, Neptune A, Adams C, et al. Antiretroviral stewardship in a pediatric HIV clinic: development, Implementation, and Improved Clinical Outcomes. Pediatr Infect Dis J. 2016;35(6):642–648.
   PubMed Web of Science ®Google Scholar
• Castel AD, Qasmieh S, Greenberg D, et al. Digital gaming to improve adherence among adolescents and young adults living with HIV: mixed-methods study to test feasibility and acceptability. JMIR Serious Games. 2018;6(4):e10213.
   PubMed Web of Science ®Google Scholar
• Fernandez C, van Halsema CL. Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential. HIV AIDS (Auckl). 2019;11:179–192.
   PubMedGoogle Scholar
• Weld ED, Rana MS, Dallas RH, et al. Interest of youth living with HIV in long-acting antiretrovirals. J Acquir Immune Defic Syndr. 2019;80(2):190–197.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents - Full Text View. [cited 2020 Mar 2]. https://clinicaltrials.gov/ct2/show/NCT03497676
   Google Scholar
• Navarro J, González-Cordón A, Casado JL, et al. Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study. Oxford Acad. 2020;75:1955–1960.
   Google Scholar
• Moreno S, Perno CF, Mallon PW, et al. Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch? HIV Medicine. 2019; [cited 2020 Aug 17]. http://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.12716
   Google Scholar
• Das D Two-drug regimens comparable with three-drug regimens for HIV. Infectious Disease Advisor. CROI. 2020. [cited 2020 Aug 20]. https://www.infectiousdiseaseadvisor.com/home/meetings/croi-2020/2-drug-antiretroviral-therapies-as-effective-as-3-drug-regimens-for-people-with-hiv/
   Google Scholar
• Rossetti B, Montagnani F, De Luca A. Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients. Expert Opin Pharmacother. 2020;19:713–738.
   Web of Science ®Google Scholar
• Frontiers. Lessons learned from failures and success stories of HIV breakthroughs: are we getting closer to an HIV cure? [cited 2020 May 29. https://www.frontiersin.org/articles/10.3389/fmicb.2020.00046/full
   Google Scholar
• Rainwater-Lovett K, Uprety P, Persaud D. Advances and hope for perinatal HIV remission and cure in children and adolescents. Curr Opin Pediatr. 2016;28(1):86–92.
   PubMed Web of Science ®Google Scholar
• Rosser JC, Vignesh V, Terwilliger BA, et al. Surgical and medical applications of drones: a comprehensive review. JSLS. 2018;22:3.
   Web of Science ®Google Scholar